All Stories

  1. PD‐L1, PD‐1, and CTLA‐4 mRNA In Situ Expression by Canine Oral Melanoma Cells and Immune Cells of the Tumour Microenvironment
  2. Diagnostic Findings and Surgical Management of Three Dogs Affected by Osseous Metaplasia Secondary to a Salivary Mucocele
  3. Sentinel lymph node mapping with computed tomography lymphography for mast cell tumours and a comparison between regional and sentinel lymph node histological status: Sixty‐two cases
  4. Surgical Excision of Intramuscular Sarcomas: Description of Three Cases in Dogs
  5. Improving Osteosarcoma Treatment: Comparative Oncology in Action
  6. Random mucosal rotating flaps for rostral to mid maxillary defect reconstruction: 26 dogs (2000‐2019)
  7. The mitotic regulator polo‐like kinase 1 as a potential therapeutic target for c‐Myc‐overexpressing canine osteosarcomas
  8. Treatment of an aneurysmal bone cyst in a young dog: A case report
  9. Canine Epithelial Thymic Tumors: Outcome in 28 Dogs Treated by Surgery
  10. Superficial temporal axial pattern flap for facial reconstruction of skin defects in dogs and cats
  11. Prognostic Value of Ki67 and Other Clinical and Histopathological Factors in Canine Apocrine Gland Anal Sac Adenocarcinoma
  12. Benign or Low-Grade Malignant Masses Occupying the Pelvic Canal Space in 11 Dogs
  13. Surgical treatment and outcome of sterile prostatic cysts in dogs
  14. Complications between ventral and lateral approach for mandibular and sublingual sialoadenectomy in dogs with sialocele
  15. Evaluation of prognostic impact of pre‐treatment neutrophil to lymphocyte and lymphocyte to monocyte ratios in dogs with oral malignant melanoma treated with surgery and adjuvant CSPG4‐antigen electrovaccination: an explorative study
  16. Deep Vegetal Foreign Bodies in Cats: A Retrospective Study of 10 Cases
  17. Naturally occurring cancers in pet dogs as pre-clinical models for cancer immunotherapy
  18. Canine mammary tumour cells exposure to sevoflurane: effects on cell proliferation and neuroepithelial transforming gene 1 expression
  19. The Italian‐Canine Cancer Biobank: Our 10‐year challenge
  20. PDGFR‐α, PDGFR‐β, VEGFR‐2 and CD117 expression in canine mammary tumours and evaluation of the in vitro effects of toceranib phosphate in neoplastic mammary cell lines
  21. The impact of extirpation of non-palpable/normal-sized regional lymph nodes on staging of canine cutaneous mast cell tumours: A multicentric retrospective study
  22. Long-term outcome of permanent tracheostomy in 15 dogs with severe laryngeal collapse secondary to brachycephalic airway obstructive syndrome
  23. Combined caudal-superficial-epigastric axial pattern flap and full-thickness buccal mucosa graft for single-stage preputial reconstruction in six dogs
  24. Strengths and Weaknesses of Pre-Clinical Models for Human Melanoma Treatment: Dawn of Dogs’ Revolution for Immunotherapy
  25. Total prostatectomy as a treatment for prostatic carcinoma in 25 dogs
  26. CSPG4: a prototype oncoantigen for translational immunotherapy studies
  27. Comparative Assessment of the Accuracy of Cytological and Histologic Biopsies in the Diagnosis of Canine Bone Lesions
  28. Prolongation of survival of dogs with oral malignant melanoma treated byen blocsurgical resection and adjuvant CSPG4-antigen electrovaccination
  29. Efficacy of systemic adjuvant therapies administered to dogs after excision of oral malignant melanomas: 151 cases (2001–2012)
  30. CSPG4-Specific Immunity and Survival Prolongation in Dogs with Oral Malignant Melanoma Immunized with Human CSPG4 DNA
  31. Glottic and skull indices in canine brachycephalic airway obstructive syndrome
  32. Clinical outcome of 42 dogs with scapular tumors treated by scapulectomy: A Veterinary Society of Surgical Oncology (VSSO) retrospective study (1995–2010)
  33. Expression of the aryl hydrocarbon receptor pathway and cyclooxygenase-2 in dog tumors
  34. PDGFs and PDGFRs in canine osteosarcoma: New targets for innovative therapeutic strategies in comparative oncology
  35. Double-J ureteral stenting in nine cats with ureteral obstruction
  36. European consensus document on mast cell tumours in dogs and cats
  37. Expression of Ki67, BCL-2, and COX-2 in Canine Cutaneous Mast Cell Tumors
  38. A case of feline injection-site sarcoma at the site of cisplatin injections
  39. Neoadjuvant chemoradiotherapy and surgery as treatment for oral maxillary squamous cell carcinoma in a dog
  40. Immunohistochemical investigation of cell cycle and apoptosis regulators (Survivin, β-Catenin, P53, Caspase 3) in canine appendicular osteosarcoma
  41. Chondroitin sulfate proteoglycan-4: A biomarker and a potential immunotherapeutic target for canine malignant melanoma
  42. Heat shock protein expression in canine osteosarcoma
  43. Biology, diagnosis and treatment of canine appendicular osteosarcoma: Similarities and differences with human osteosarcoma
  44. Feline injection-site sarcoma: Past, present and future perspectives
  45. Pleural omentalisation with en bloc ligation of the thoracic duct and pericardiectomy for idiopathic chylothorax in nine dogs and four cats
  46. Proteasomes are not a Target for Doxorubicin in Feline Injection-Site Sarcoma
  47. Bone invading NSCLC cells produce IL-7: mice model and human histologic data
  48. met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre‐clinical model of human osteosarcoma
  49. Marginal Excision of Low-Grade Spindle Cell Sarcoma of Canine Extremities: 35 Dogs (19962006)
  50. Transanal Pull‐Through Rectal Amputation for Treatment of Colorectal Carcinoma in 11 Dogs
  51. A Mouse Model of Pulmonary Metastasis from Spontaneous Osteosarcoma Monitored In Vivo by Luciferase Imaging
  52. Enhanced Expression of Interferon-γ-Induced Antigen-Processing Machinery Components in a Spontaneously Occurring Cancer
  53. Endoscopic bronchial anatomy in the cat
  54. Immunohistochemical Study of STAT3 Expression in Feline Injection-site Fibrosarcomas
  55. Surgery alone versus surgery and doxorubicin for the treatment of feline injection-site sarcomas: a report on 69 cases
  56. Adrenal Myelolipoma in a Dog
  57. Reversal of multidrug-resistance using Valspodar® (PSC 833) and doxorubicin in osteosarcoma
  58. Pasteurized Tumoral Autograft as a Novel Procedure for Limb Sparing in the Dog: A Clinical Report
  59. Vaccine-associated-like Fibrosarcoma at the Site of a Deep Nonabsorbable Suture in a Cat
  60. Bone allografts and adjuvant cisplatin for the treatment of canine appendicular osteosarcoma in 18 dogs
  61. Met oncogene aberrant expression in canine osteosarcoma
  62. Osteomyelitis and arthrosynovitis associated with Leishmania donovani infection in a dog
  63. Large granular lymphoma in an FIV‐positive and FeLV‐negative cat